Dr. Anna Brożyna
Editorial Board Member
Melanoma biology · vitamin D & nuclear receptors
Nicolaus Copernicus University, Toruń
Editorial board · Peer-reviewed · Open access
Editorial Board
An international board of cancer geneticists, molecular oncologists, and pathologists who steward peer review and scientific quality at JCGB.
20Board members
10Countries
12ORCID-verified
The board
Members of the JCGB editorial board
Each member is an active researcher in cancer genetics, genomics, molecular oncology, pathology, or biomarker science. Expertise and affiliations are shown as verified; an ORCID iD is linked wherever it has been confirmed against the ORCID registry.
20 members
No matching members
No board members match your search or filter. Try a different term, or clear to see the full board.
Dr. Xinyu Chen
Editorial Board Member
Cancer metabolism · translational research
University of Illinois at Chicago
United States
ORCID profile for Xinyu ChenORCID
Dr. Runjan Chetty
Editorial Board Member
Colorectal & pancreatic molecular pathology
University of Toronto / Toronto General Hospital
Dr. Zarmina Ehtesham
Editorial Board Member
Oral, head & neck cancer
Hamdard University, Karachi
Dr. Charlie Gourley
Editorial Board Member
Ovarian cancer · molecular subtypes
Edinburgh Cancer Research Centre, Western General Hospital
United Kingdom
ORCID profile for Charlie GourleyORCID
Dr. Shilpi Gupta
Editorial Board Member
HPV · cancer stem cells · tumour markers
Amity University, Noida
Dr. Guru Prasad Maiti
Editorial Board Member
Cancer biology · gene expression
Oklahoma Medical Research Foundation
United States
ORCID profile for Guru Prasad MaitiORCID
Dr. Kumar Pranav Narayan
Editorial Board Member
Cancer diagnostics & therapeutics
BITS Pilani, Hyderabad Campus
Dr. Krzysztof Roszkowski
Editorial Board Member
Radiotherapy · oxidative-DNA-damage biomarkers
Nicolaus Copernicus University, Collegium Medicum, Bydgoszcz
Dr. Ankita Singh
Editorial Board Member
Cancer genetics · tumorigenesis · cell signalling
Harvard Medical School
United States
ORCID profile for Ankita SinghORCID
Dr. Ladan Teimoori-Toolabi
Editorial Board Member
Cancer epigenetics · drug resistance · biomarkers
Pasteur Institute of Iran
Dr. Maciej Wnuk
Editorial Board Member
Senescence · DNA methylation · molecular cytogenetics
University of Rzeszów
Dr. Swapna Apte-Sengupta
Editorial Board Member
Biomarkers · drug targets · proteomics
Purdue University
United States
Dr. Yu Cao
Editorial Board Member
Tumour immunology · gene expression
Moffitt Cancer Center
United States
Dr. Mariantonietta Colozza
Editorial Board Member
Clinical oncology · HER2 · cancer therapy
Azienda Ospedaliera Santa Maria di Terni
Italy
Dr. Joshua Curtin
Editorial Board Member
Cancer biology · drug discovery
Bristol-Myers Squibb
United States
Dr. Hou YC
Editorial Board Member
Tumour signal transduction · tumour-related genes
China
Dr. Murat Kara
Editorial Board Member
Cancer miRNA · gene expression
Muğla Sıtkı Koçman University
Turkey
Dr. Bijoy Kumar Mohanty
Editorial Board Member
Molecular biology · genetics
University of Georgia
United States
Dr. Yi Shan
Editorial Board Member
Leukaemia · lymphoma · targeted gene therapy
UMass Chan Medical School
United States
Board membership reflects each editor’s verified scholarly record. Some members do not have a public ORCID iD on record; where an iD could not be independently confirmed it is omitted rather than guessed. Editors recuse themselves from any manuscript in which they have a conflict of interest.
Governance & accountability
How the board upholds scientific quality
The editorial board is responsible for the scholarly integrity of everything JCGB publishes. Editorial decisions rest on scientific merit and are independent of fees, membership, or any paid service.
What the board does
- Peer-review oversight. Editors assess each submission for fit and rigour and assign qualified reviewers. Review is single-blind (double-blind on request).
- Scope stewardship. The board keeps JCGB focused on cancer genetics, genomics, molecular oncology, and biomarker research.
- Research integrity. Concerns about misconduct, data, or ethics are handled in line with COPE guidance, including corrections and retractions where warranted.
- Confidentiality. Submissions and reviewer identities are treated as confidential throughout the process.
Independence & conflicts of interest
Editors and reviewers declare competing interests and recuse themselves from handling their own submissions or any work where a conflict exists; those manuscripts are managed independently. Payment of an article processing charge, membership, or use of any optional service confers no advantage in review or the likelihood of acceptance.
The board, JCGB & Open Access Pub
The editorial board provides scholarly governance and makes editorial decisions. Open Access Pub, the publisher, provides production, hosting, Crossref DOIs, and preservation infrastructure — it does not make acceptance decisions.
Work with the board
Submit your research — or help review it.
Researchers in cancer genetics and biomarkers who would like to be considered for a reviewer or editorial role are welcome to write to the editorial office with a CV and areas of expertise.